Metabolic Suppression by 3-Iodothyronamine Induced Muscle Cell Atrophy via Activation of FoxO-Proteasome Signaling and Downregulation of Akt1-S6K Signaling.
The homeostasis of muscle properties depends on both physical and metabolic stresses. Whereas physical stress entails metabolic response for muscle homeostasis, the latter does not necessarily involve the former and may thus solely affect the homeostasis. We here report that metabolic suppression by the hypometabolic agent 3-iodothyronamine (T1AM) induced muscle cell atrophy without physical stress. We observed that the oxygen consumption rate of C2C12 myotubes decreased 40% upon treatment with 75 µM T1AM for 6 h versus 10% in the vehicle (dimethyl sulfoxide) control. The T1AM treatment reduced cell diameter of myotubes by 15% compared to the control (p<0.05). The cell diameter was reversed completely by 9 h after T1AM was removed. The T1AM treatment also significantly suppressed the expression levels of heat shock protein 72 and αB-crystallin as well as the phosphorylation levels of Akt1, mammalian target of rapamycin (mTOR), S6K, forkhead box O1 (FoxO1) and FoxO3. In contrast, the levels of ubiquitin E3 ligase MuRF1 and chymotrypsin-like activity of proteasome were significantly elevated by T1AM treatment. These results suggest that T1AM-mediated metabolic suppression induced muscle cell atrophy via activation of catabolic signaling and inhibition of anabolic signaling.
Division of Biological Science and Technology, College of Science and Technology, Yonsei University.
Hyunwoo
H
Ju
Division of Biological Science and Technology, College of Science and Technology, Yonsei University.
Taewan
T
Kim
Department of Chemistry and Medical Chemistry, College of Science and Technology, Yonsei University.
Chan-Moon
CM
Chung
Division of Biological Science and Technology, College of Science and Technology, Yonsei University.
Junsoo
J
Park
Department of Nutritional Physiology, Institute of Health Biosciences, University of Tokushima Graduate School.
Takeshi
T
Nikawa
Sungkyunkwan University School of Medicine.
Kyoungsook
K
Park
Division of Biological Science and Technology, College of Science and Technology, Yonsei University.
Inho
I
Choi
D000818:Animals; D002478:Cells, Cultured; D015536:Down-Regulation; D000071161:Forkhead Box Protein O1 / Q000502:physiology*; D051379:Mice; D018485:Muscle Fibers, Skeletal; D009133:Muscular Atrophy / Q000139:chemically induced*; D046988:Proteasome Endopeptidase Complex / Q000502:physiology*; D051057:Proto-Oncogene Proteins c-akt / Q000502:physiology*; D019893:Ribosomal Protein S6 Kinases / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*; D058570:TOR Serine-Threonine Kinases / Q000502:physiology; D013970:Thyronines / Q000494:pharmacology*
C487948:3-iodothyronamine; D000071161:Forkhead Box Protein O1; C467200:Foxo1 protein, mouse; D013970:Thyronines; D051057:Proto-Oncogene Proteins c-akt; D019893:Ribosomal Protein S6 Kinases; D058570:TOR Serine-Threonine Kinases; D046988:Proteasome Endopeptidase Complex
3-iodothyronamine; C2C12 myotube; anabolism; catabolism; hypometabolism; muscle atrophy